Anatomic Pathology Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Anatomic Pathology Market By Product (Services (Cytopathology, Histopathology), Instruments (Slide Strainer, Tissue Processor, Microtomes), Consumables (Antibodies, Reagents)), By Application (Drug Discovery, Diagnosis), By End User (Hospitals, Research Organization, Diagnostic Centres), and Geography (North America, Latin America, Europe, Asia pacific and Middle East and africa)

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Anatomic Pathology Market size was valued at USD 37.9 billion in 2021 and is expected to reach a value of USD 58.9 billion by 2028 witnessing a CAGR rate of 6.5% during the forecast period 2022-2028.  This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the Anatomic Pathology Market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the Anatomic Pathology Market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product opportunities). The anatomic pathology is a branch of science that involves in molecular, biochemical and microscopic analysis of tissues and organs in order to find the effectiveness of diseases. The main objective of anatomic pathology is the identification of abnormalities to manage treatment and diagnosis. This can be helpful diagnosis of different types of cancers. The global anatomic pathology market is surging owing to frequent acquisitions and collaborations by the market players. For instance, In November 2018, Quest Diagnostics, Inc. agreed to acquire the assets of the clinical laboratory services business of Boyce and Bynum Pathology Laboratories or BBPL including anatomic pathology services. Moreover, In December 2018, Sonic Healthcare acquired Aurora Diagnostics to expand its anatomic pathology services in U.S.

 

 

Anatomic Pathology Market

MARKET SUMMARY
-
6.5%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 6.5%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Anatomic Pathology Market

  • The report gives a comprehensive outlook on Anatomic Pathology across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
  • The report gives historical, current, and future market sizes (US$ Bn) on the Product, Instruments, Consumables, By Application, By End User and Geography.
  • Key stakeholders of the market report include suppliers, manufacturers, marketers, policymakers, and healthcare service providers engaged in the Anatomic Pathology market.
Key Players
  • Thermo Fisher Scientific (U.S.)
  • Hoffmann-La Roche AG (Switzerland)
  • Danaher Corporation (U.S.)
  • Sakura Finetechnical Co., Ltd. (Japan)
  • Agilent Technologies (U.S.)
Drivers and Restrains

Anatomic Pathology Market

Anatomic Pathology market is driven by growing prevalence of chronic disease, increase in geriatric population, rise in initiatives taken by the government in order to prevent the diseases. Furthermore, rise in incidence of STD’s, changes in lifestyle of people, increase in awareness regarding diseases and their preventive measures are expected to propel the growth of the market. On the other hand, lack of awareness in developing countries, high cost of the process are dampen the anatomic pathology market.Based on end-user, hospitals accounted for larger market revenue share  and projected gain market revenue share over the forecast period. Players focusing on innovation of newer products and collaboration strategies to retain market position in global anatomic pathology market


North America dominates the market

Anatomic Pathology Market

Geographically Anatomic Pathology Market is segmented as Latin America, Europe, Asia Pacific, North America, and Middle East and Africa. North America is expected to remain the dominant market in global anatomic pathology market throughout the forecast period, followed by Europe due to more number of players are expected to enter into the former market during the forecast period. Japan is expected to be the next lucrative market for companies, and the market is estimated to register good revenue over the forecast period. Asia Pacific is expected to grow at the fastest CAGR during the forecast period due to rising penetration of the digital imaging in emerging economies, growing investments in medical field, and the presence of untapped opportunities. Asia Pacific healthcare industry has highly influenced the anatomic pathology due to increased incidence of cancer, geriatric population pool. Increasing demand for novel treatment options, better patient care facilities, and reduction in laboratory expenses are expected to drive demand in the coming years.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2017-2021) and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Anatomic Pathology Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content


Report

Company Profile

  • Thermo Fisher Scientific (U.S.)
  • Hoffmann-La Roche AG (Switzerland)
  • Danaher Corporation (U.S.)
  • Sakura Finetechnical Co., Ltd. (Japan)
  • Agilent Technologies (U.S.)
  • Quest Diagnostics Incorporated (U.S.)
  • NeoGenomics Laboratories, Inc. (U.S.)
  • Laboratory Corporation of America Holdings (U.S.)

Description

Anatomic Pathology Market size was valued at USD 37.9 billion in 2021 and is expected to reach a value of USD 58.9 billion by 2028 witnessing a CAGR rate of 6.5% during the forecast period 2022-2028.  This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the Anatomic Pathology Market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the Anatomic Pathology Market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product opportunities). The anatomic pathology is a branch of science that involves in molecular, biochemical and microscopic analysis of tissues and organs in order to find the effectiveness of diseases. The main objective of anatomic pathology is the identification of abnormalities to manage treatment and diagnosis. This can be helpful diagnosis of different types of cancers. The global anatomic pathology market is surging owing to frequent acquisitions and collaborations by the market players. For instance, In November 2018, Quest Diagnostics, Inc. agreed to acquire the assets of the clinical laboratory services business of Boyce and Bynum Pathology Laboratories or BBPL including anatomic pathology services. Moreover, In December 2018, Sonic Healthcare acquired Aurora Diagnostics to expand its anatomic pathology services in U.S.

 

 

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX